Cargando…
Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles
Nitrobenzothiazinone (BTZ) is a promising scaffold with potent activity against M. tuberculosis by inhibiting decaprenylphosphoryl-beta-d-ribose 2′-oxidase (DprE1). But unfavorable durability poses a challenge to further development of this class of agents. Herein, a series of BTZs bearing a variety...
Autores principales: | Xiong, Lu, Gao, Chao, Shi, Yao-Jie, Tao, Xin, Rong, Juan, Liu, Kun-Lin, Peng, Cui-Ting, Wang, Ning-Yu, Lei, Qian, Zhang, Yi-Wen, Yu, Luo-Ting, Wei, Yu-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078972/ https://www.ncbi.nlm.nih.gov/pubmed/35541526 http://dx.doi.org/10.1039/c8ra00720a |
Ejemplares similares
-
2-Chloro-3-nitro-5-(trifluoromethyl)benzoic acid and -benzamide: structural characterization of two precursors for antitubercular benzothiazinones
por: Richter, Adrian, et al.
Publicado: (2021) -
Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity
por: Fan, Dongguang, et al.
Publicado: (2023) -
Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis
por: de Jesus Lopes Ribeiro, Ana Luisa, et al.
Publicado: (2011) -
Effects of benzothiazinone and ethambutol on the integrity of the corynebacterial cell envelope
por: Meyer, Fabian M., et al.
Publicado: (2023) -
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
por: Makarov, Vadim, et al.
Publicado: (2014)